GLTO Insider Filing: 720 Options Granted to Director at $3.22

Rhea-AI Filing Summary

Galecto, Inc. (GLTO) – Form 4 insider filing

On 18 June 2025, non-employee director Dallas Jayson Donald Alexander received an automatic grant of 720 stock options under the company’s Director Compensation Policy. The options carry an exercise price of $3.22 per share, a 10-year term expiring 18 June 2035, and will vest in equal monthly installments over one year. The filing lists the director’s ownership as direct and discloses no sales or other equity transactions.

Given the small size of the grant and its routine nature, the disclosure is unlikely to have a material impact on Galecto’s valuation or trading dynamics; however, it does incrementally align director incentives with shareholder value through equity-based compensation.

Insights

Securities Analyst

TL;DR: Routine 720-option grant; negligible market impact.

The Form 4 records a standard annual equity award to a non-employee director—720 options at $3.22, vesting monthly over 12 months. The nominal value is immaterial relative to Galecto’s market cap, and no shares were sold. Such grants are typical for governance alignment and do not alter ownership concentration meaningfully. I view the filing as neutral for investors, providing transparency rather than signaling operational or financial change.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Dallas Jayson Donald Alexander

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	720	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 720 shares (Direct)

Footnotes (1)

1. F1. Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.

FAQ

What did GLTO disclose in the 18 June 2025 Form 4?

A grant of 720 stock options to director Dallas J. D. Alexander at an exercise price of $3.22.

What is the exercise price of the newly granted Galecto options?

Each option has an exercise price of $3.22 per share.

When will the GLTO director options vest?

The 720 options vest monthly over the 12 months following 18 June 2025.

When do the granted options to the Galecto director expire?

The options have a 10-year term and expire on 18 June 2035.

Did the director sell any Galecto shares in this filing?

No. The Form 4 shows only an option grant; no shares were sold or disposed of.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 06/20/2025 - 07:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dallas Jayson Donald Alexander

(Last) (First) (Middle)

OLE MAALOES VEJ 3

C/O GALECTO, INC.

(Street)

COPENHAGEN N G7 G7 DK-2200

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Galecto, Inc. [ GLTO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$3.22	06/18/2025		A		720		(1)	06/18/2035	Common Stock	720	$0	720	D

Explanation of Responses:

1. Pursuant to the Issuer's Non-Employee Director Compensation Policy, this option was automatically granted on June 18, 2025, the date of the Issuer's 2025 Annual Meeting of Stockholders, with shares subject to the option vesting in equal monthly installments until the first anniversary of the grant date.

	/s/ Hans T. Schambye, attorney-in-fact	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.